Palvella Therapeutics, Inc. (PVLA) Assets Average (2016 - 2022)
Palvella Therapeutics (PVLA) has disclosed Assets Average for 11 consecutive years, with $22.8 million as the latest value for Q3 2024.
- On a quarterly basis, Assets Average fell 68.98% to $22.8 million in Q3 2024 year-over-year; TTM through Sep 2024 was $22.8 million, a 68.98% decrease, with the full-year FY2023 number at $51.5 million, down 58.63% from a year prior.
- Assets Average was $22.8 million for Q3 2024 at Palvella Therapeutics, down from $27.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $159.6 million in Q3 2021 to a low of $18.5 million in Q1 2024.
- A 5-year average of $98.4 million and a median of $110.4 million in 2020 define the central range for Assets Average.
- Peak YoY movement for Assets Average: skyrocketed 43.95% in 2021, then crashed 79.16% in 2024.
- Palvella Therapeutics' Assets Average stood at $110.4 million in 2020, then skyrocketed by 43.95% to $158.9 million in 2021, then plummeted by 38.74% to $97.3 million in 2022, then plummeted by 65.62% to $33.5 million in 2023, then tumbled by 31.9% to $22.8 million in 2024.
- Per Business Quant, the three most recent readings for PVLA's Assets Average are $22.8 million (Q3 2024), $27.3 million (Q2 2024), and $18.5 million (Q1 2024).